| Imprint of human cytomegalovirus infection on the NK cell receptor repertoire M Gumá, A Angulo, C Vilches, N Gómez-Lozano, N Malats, ... Blood 104 (12), 3664-3671, 2004 | 942 | 2004 |
| A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reyniès, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 929 | 2020 |
| Prognosis Research Strategy (PROGRESS) 2: prognostic factor research RD Riley, JA Hayden, EW Steyerberg, KGM Moons, K Abrams, PA Kyzas, ... PLoS medicine 10 (2), e1001380, 2013 | 806 | 2013 |
| NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses M García-Closas, N Malats, D Silverman, M Dosemeci, M Kogevinas, ... The Lancet 366 (9486), 649-659, 2005 | 763 | 2005 |
| Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools CM Villanueva, KP Cantor, JO Grimalt, N Malats, D Silverman, A Tardon, ... American journal of epidemiology 165 (2), 148-156, 2007 | 725 | 2007 |
| Detectable clonal mosaicism and its relationship to aging and cancer KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ... Nature genetics 44 (6), 651-658, 2012 | 664 | 2012 |
| Comprehensive transcriptional analysis of early-stage urothelial carcinoma J Hedegaard, P Lamy, I Nordentoft, F Algaba, S Høyer, BP Ulhøi, S Vang, ... Cancer cell 30 (1), 27-42, 2016 | 582 | 2016 |
| EphB receptor activity suppresses colorectal cancer progression E Batlle, J Bacani, H Begthel, S Jonkeer, A Gregorieff, M Van De Born, ... Nature 435 (7045), 1126-1130, 2005 | 511 | 2005 |
| A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci N Rothman, M Garcia-Closas, N Chatterjee, N Malats, X Wu, JD Figueroa, ... Nature genetics 42 (11), 978-984, 2010 | 506 | 2010 |
| Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, ... Journal of Clinical Oncology 15 (8), 2866-2872, 1997 | 447 | 1997 |
| Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas S Hernández, E López-Knowles, J Lloreta, M Kogevinas, A Amorós, ... Journal of Clinical Oncology 24 (22), 3664-3671, 2006 | 398 | 2006 |
| Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage M Porta, X Fabregat, N Malats, L Guarner, A Carrato, A De Miguel, L Ruiz, ... Clinical and Translational Oncology 7, 189-197, 2005 | 391 | 2005 |
| P53 as a prognostic marker for bladder cancer: a meta-analysis and review N Malats, A Bustos, CM Nascimento, F Fernandez, M Rivas, D Puente, ... The lancet oncology 6 (9), 678-686, 2005 | 373 | 2005 |
| Epidemiology of urinary bladder cancer: from tumor development to patient’s death C Murta-Nascimento, BJ Schmitz-Dräger, MP Zeegers, G Steineck, ... World journal of urology 25, 285-295, 2007 | 357 | 2007 |
| Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer BM Wolpin, C Rizzato, P Kraft, C Kooperberg, GM Petersen, Z Wang, ... Nature genetics 46 (9), 994-1000, 2014 | 340 | 2014 |
| Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy C Balbás-Martínez, A Sagrera, E Carrillo-de-Santa-Pau, J Earl, ... Nature genetics 45 (12), 1464-1469, 2013 | 321 | 2013 |
| Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome Y Allory, W Beukers, A Sagrera, M Flández, M Marqués, M Márquez, ... European urology 65 (2), 360-366, 2014 | 300 | 2014 |
| A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis H Witt, M Sahin-Tóth, O Landt, JM Chen, T Kähne, JPH Drenth, Z Kukor, ... Nature genetics 38 (6), 668-673, 2006 | 288 | 2006 |
| PIK3CA Mutations Are an Early Genetic Alteration Associated with FGFR3 Mutations in Superficial Papillary Bladder Tumors E López-Knowles, S Hernández, N Malats, M Kogevinas, J Lloreta, ... Cancer research 66 (15), 7401-7404, 2006 | 285 | 2006 |
| Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study LE Moore, RM Pfeiffer, C Poscablo, FX Real, M Kogevinas, D Silverman, ... The lancet oncology 9 (4), 359-366, 2008 | 281 | 2008 |
